 Triazolam
"Triazolam" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Descriptor ID |
D014229
|
| MeSH Number(s) |
D03.438.079.080.900
|
| Concept/Terms |
Halcion- Halcion
- Pfizer Brand of Triazolam
- Triazolam Pfizer Brand
Trilam- Trilam
- Gerard Brand of Triazolam
Apo-Triazo- Apo-Triazo
- Apo Triazo
- Apotex Brand of Triazolam
Gen-Triazolam- Gen-Triazolam
- Gen Triazolam
- Genpharm Brand of Triazolam
|
Below are MeSH descriptors whose meaning is more general than "Triazolam".
Below are MeSH descriptors whose meaning is more specific than "Triazolam".
This graph shows the total number of publications written about "Triazolam" by people in this website by year, and whether "Triazolam" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 1 | 0 | 1 | | 1995 | 1 | 0 | 1 | | 2002 | 1 | 0 | 1 | | 2006 | 0 | 1 | 1 | | 2012 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Triazolam" by people in Profiles.
-
Carter LP, Reissig CJ, Johnson MW, Klinedinst MA, Griffiths RR, Mintzer MZ. Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans. Drug Alcohol Depend. 2013 Mar 01; 128(3):206-13.
-
Reissig CJ, Carter LP, Johnson MW, Mintzer MZ, Klinedinst MA, Griffiths RR. High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens. Psychopharmacology (Berl). 2012 Sep; 223(1):1-15.
-
Johnson MW, Suess PE, Griffiths RR. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. Arch Gen Psychiatry. 2006 Oct; 63(10):1149-57.
-
Gomez TH, Roache JD, Meisch RA. Orally delivered alprazolam, diazepam, and triazolam as reinforcers in rhesus monkeys. Psychopharmacology (Berl). 2002 Apr; 161(1):86-94.
-
Roache JD, Meisch RA, Henningfield JE, Jaffe JH, Klein S, Sampson A. Reinforcing effects of triazolam in sedative abusers: correlation of drug liking and self-administration measures. Pharmacol Biochem Behav. 1995 Feb; 50(2):171-9.
-
Spiga R, Cherek DR, Meisch RA, Roache JD. Human multioperant responding: effects of triazolam. NIDA Res Monogr. 1989; 95:477-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|